EGFR and bone metastasis: Since the combination of gefitinib and radiotherapy resulted in early osteosclerosis and long-lasting local control of bone metastases, we reasonably speculate that this is the best treatment for symptomatic patients with osteolytic bone metastasis at critical sites such as the thoracic spine, acetabulum, and femur and harboring EGFR mutations.